226351
N-羟基马来酰亚胺
97%, for peptide synthesis
别名:
1-羟基吡咯-2,5-二酮
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C4H3NO3
化学文摘社编号:
分子量:
113.07
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352005
EC Number:
225-385-4
MDL number:
Beilstein/REAXYS Number:
1524594
产品名称
N-羟基马来酰亚胺, 97%
InChI key
BUXKULRFRATXSI-UHFFFAOYSA-N
InChI
1S/C4H3NO3/c6-3-1-2-4(7)5(3)8/h1-2,8H
SMILES string
ON1C(=O)C=CC1=O
assay
97%
form
solid
reaction suitability
reaction type: Addition Reactions
mp
130-133 °C (dec.) (lit.)
application(s)
peptide synthesis
functional group
imide
maleimide
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
N-羟基马来酰亚胺可作为氧化剂，原位生成N-羟基苯胺类物质，这种物质是N-取代苯胺和羟胺衍生物经由选择性偶联反应高效合成芳肟的重要中间体。
General description
N-羟基马来酰亚胺(NHMI)是一种有机化合物，广泛用作有机合成的氧化剂。常用于将硫醇选择性氧化为二硫化物，也用于α,β-不饱和羰基化合物的合成。还可作为Michael受体，用于多肽和蛋白质的合成。
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Skin Corr. 1B
存储类别
8A - Combustible corrosive hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
Minye Yang et al.
Nanoscale, 10(33), 15865-15874 (2018-08-15)
The detection of mycotoxins in food is urgently needed because they pose a significant threat to public health. In this study, we developed a quantitative detection platform for mycotoxins by integrating multicolor upconversion nanoparticle barcode technology with fluorescence image processing
Jamerson Carneiro de Oliveira et al.
Molecules (Basel, Switzerland), 25(2) (2020-01-16)
The study of Diels-Alder reactions in materials science is of increasing interest. The main reason for that is the potential thermoreversibility of the reaction. Aiming to predict the behavior of a material modified with maleimido and furyl moieties, 1H NMR
Yusuke Hibi et al.
Nature communications, 7, 11064-11064 (2016-03-22)
There is a growing interest in sequence-controlled polymers toward advanced functional materials. However, control of side-chain order for vinyl polymers has been lacking feasibility in the field of polymer synthesis because of the inherent feature of chain-growth propagation. Here we
Moon Soo Gil et al.
Journal of controlled release : official journal of the Controlled Release Society, 267, 119-132 (2017-04-17)
Biological drugs are exquisitely tailored components offering the advantages of high specificity and efficacy that are considered safe for treating diseases. Nevertheless, the effectiveness of biological drugs is limited by their inherent short biological half-life and poor stability in vivo.
Jinhwan Cho et al.
Journal of controlled release : official journal of the Controlled Release Society, 324, 532-544 (2020-05-27)
Therapeutic proteins are attractive candidates for the treatment of human diseases. However, their short half-life often limits their clinical application. To overcome this problem, injectable hydrogels have been developed as depots for controlled release of therapeutic proteins, but these systems
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持